Moxibustion enhances the antitumor efficacy of Trametinib in breast cancer-bearing mice via MEK/ERK signaling pathway

ObjectiveTo explore the synergistic inhibitory effect of moxibustion and mitogen-activated protein kinase kinase （MEK）/ extracellular regulated protein kinases （ERK） pathway inhibitor Trametinib on tumor growth in breast cancer tumor-bearing mice and to analyze its underlying mechanisms.MethodsFifty...

ver descrição completa

Detalhes bibliográficos

Principais autores:	LI Ji-juan, ZHANG Chen-xi, LIANG Xin-yue, MA Yu, LIU Jing-xuan, JIA Chun-sheng, PAN Li-jia
Formato:	Artigo
Idioma:	Chinês
Publicado em:	Editorial Office of Acupuncture Research 2026-04-01
coleção:	针刺研究
Assuntos:	Moxibustion Breast cancer MEK/ERK pathway Trametinib Synergistic anticancer Programmed cell death ligand 1
Acesso em linha:	http://www.zhenciyanjiu.cn/thesisDetails#10.13702/j.1000-0607.20251015
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!